Dietary Omega-3 Fatty Acid, Ratio of Omega-6 to Omega-3 Intake, Inflammation, and Survival in Long-term Hemodialysis Patients
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background Mortality among long-term hemodialysis patients is high, mostly attributed to cardiovascular events, and may be related to chronic inflammation. We hypothesized that the anti-inflammatory benefits of higher dietary omega-3, compared to omega-6, poly-unsaturated fatty acids may modulate the inflammatory processes and reduce death risk. Study design Prospective cohort study using linear and Cox proportional regressions. Setting and Participants 145 hemodialysis patients from 8 DaVita dialysis clinics in Southern California during 2001-2007 Predictors Intake of dietary omega-3 and ratio of omega-6 to omega-3 using 3-day food record supplemented by dietary interview. Outcomes One-year change in serum C-reactive protein (CRP) and 6-year survival. Results Patients were 53±14 years old (mean±SD) and included 43% women and 42% African-Americans. Median (25th-75 percentile) of dietary omega-3 intake, ratio of omega-6 to omega-3 intake, baseline serum CRP, and change in CRP over one year were 1.1(0.8-1.6) g/day, 9.3(7.6-11.3), 3.1(0.8-6.8) mg/L, and +0.2(−0.4 to +0.8) mg/L, respectively. In regression models adjusted for case-mix, dietary calorie and fat intake, body mass index and history of hypertension, each 1-unit higher ratio of omega-6 to omega-3 intake was associated with 0.55 mg/L increase in serum CRP (p=0.03). In fully adjusted model, the death hazard ratios (95% confidence interval) for the 1st(1.7-<7.6) 2nd(7.6-<9.3), 3rd(9.3-<11.3) and 4th(11.3-17.4) quartiles of dietary omega-6 to omega-3 ratio were 0.39(0.14-1.18), 0.30(0.09-0.99), 0.67(0.25-1.79) and 1.00(reference), respectively (p-for-trend=0.06). Limitations Three-day food record may underestimate actual dietary fat intake at individual level. Conclusions Higher dietary omega-6 to omega-3 ratio appears associated with both worsening inflammation over time and a trend towards higher death risk in hemodialysis patients. Additional studies including interventional trials are needed to examine the association of dietary fatty acids with clinical outcomes in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Omega-3 fatty acids in health and disease and in growth and development.
Simopoulos, A. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.438 · Cited by 2,162 · cited 5×
“Over the past 100 years, however, the ratio of omega-6 to omega-3 in Western diets has dramatically increased to ranges of 15/1 or even higher.(10-14) A high dietary omega-6 to omega-3 ratio may contribute to cardiovascular disease, cancer, osteoporosis, and autoimmune disorders.”
BackgroundInfluentialRelationship of plasma polyunsaturated fatty acids to circulating inflammatory markers.
Ferrucci, L., Cherubini, A., Bandinelli, S., Bartali, B., Corsi, A., Lauretani, F., Martin, A., Andres-Lacueva, C., Senin, U., & Guralnik, J. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1303 · Cited by 696 · cited 1×
“Ferruci et al.(42) suggested that a higher omega-6 to omega-3 ratio was associated with higher serum interleukin-10 concentrations and concluded that omega-3 is protective against diseases characterized by active inflammation.”
BackgroundIso, H., Kobayashi, M., Ishihara, J., Sasaki, S., Okada, K., Kita, Y., Kokubo, Y., & Tsugane, S. (2006) · Circulation · doi:10.1161/circulationaha.105.581355 · Cited by 557
Cited by
Ketogenic Diet and Microbiota: Friends or Enemies?
Paoli, A., Mancin, L., Bianco, A., Thomas, E., Mota, J. F., & Piccini, F. (2019) · Genes · doi:10.3390/genes10070534 · Cited by 262
Marventano, S., Kolacz, P., Castellano, S., Galvano, F., Buscemi, S., Mistretta, A., & Grosso, G. (2015) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2015.1077790 · Cited by 220
“…have been demonstrated to be more at risk of CVD events (including ischemic heart disease, stroke, peripheral artery disease, pulmonary edema and valve disease) than paired controls with similar age and sex (Shoji et al., 2013) and significant increase of C-reactive protein (Noori et al., 2011).”
BackgroundFriedman, A. N., Yu, Z., Tabbey, R., Denski, C., Tamez, H., Wenger, J., Thadhani, R., Li, Y., & Watkins, B. A. (2013) · Kidney International · doi:10.1038/ki.2013.4 · Cited by 54
Dietary Omega-3 Fatty Acid Intake and Mortality in CKD Population: A 1999–2014 NHANES Analysis
Li, W.-L., Zhang, N.-H., Ge, S.-W., & Xu, G. (2021) · American Journal of Nephrology · doi:10.1159/000520027 · Cited by 16
Metadata
- Authors
- Noori, N., Dukkipati, R., Kovesdy, C. P., Sim, J. J., Feroze, U., Murali, S. B., Bross, R., Benner, D., Kopple, J. D., & Kalantar-Zadeh, K.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 58
- Issue
- 2
- Pages
- 248-256
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2127176760
- Cited by
- 79
- References
- 4
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.